Brother Pharmaceutical to build new 13,000t Vitamin B3 Project 05-19-2019

On April 30, the People’s Government of Pengze County, Jiujiang City, Jiangxi Province, issued the Environmental Impact Assessment of a new vitamin project of Jiangxi Brothers Pharmaceutical co., Ltd. on its website. The project will build a vitamin B3 capacity of 13,000t/a and medicinal spices of 3,000 t/a, and it will also include the construction of pharmaceutical intermediates.


The total investment of the new project is USD 35.64 million (RMB 240 million) and it will be located in Pengze County Rocky Mountain Industrial Park and the control area for printing and dyeing which is in the south area of Jiangxi Brothers Pharmaceutical co., Ltd.. The project is estimated to cover 46,330 square meters with its total gross floor area of 56,770 square meters. The construction project is divided into two phases: In the first phase, a 3-methylpyridine production line, a production line of dihydromyrcenol and pine oil are built respectively and the second phase will focus on the construction of a production line of niacinamide, a production line of niacin, a production line of furanone, and a production line of methoxy dimethyl heptanal.


Contact details of Jiangxi Brothers Pharmaceutical Co., Ltd. and the organization of the environmental impact assessment are listed. The public are also allowed to give their opinions on the project.


Jiangxi Brothers Pharmaceutical Co. plans to invest 30 hundred million RMB

Jiangxi Brothers Pharmaceutical Co., Ltd., with its stock code 002562, is an enterprise in China, with the main office in Jiujiang. It is invested by Brother Enterprises and operates in the Pharmaceutical and Medicine Manufacturing industry. The Brother Pharmaceutical project is estimated to invest 50 hundred million RMB in total. The project mainly focuses on research, production and marketing in the aspect of fine chemical industry, bio-chemical industry and pharmaceutical chemicals. The company plans to invest 30 hundred million RMB as the first investment. In 2015, the company has constructed its productions of vitamin B3, vitamin B5, and CHP (co-generation of heat and power) project and supporting facilities for CHP, with the total investment of RMB14.8 hundred million. The trial productions continued in the second quarter of 2017. In the second quarter of 2017, the company has invested about 15 hundred million RMB for the second construction project and the trial productions will be planned to start in the fourth quarter of 2018.


Brother Enterprises is a fine chemical enterprise located in Haining city, Zhejiang province and its stocks were listed on the Shenzhen Stock Exchange in 2011. Brother Enterprises has become the biggest supplier of vitamin K3 in the world, the top three supplier of vitamin B3 in the world, the top four supplier of vitamin B3 in the world, the biggest supplier of chrome tanning agent in China and the top three in the world. It is also a famous leather chemical enterprise in China.


With the first phase of the project carrying out successfully, the company will further occupy the market share of vitamin B3 and in the meanwhile, it will become one of the primary suppliers of vitamin B5 in the world.


For more information on this project and the impact on Chinese vitamin B3 supply, please have a look at our monthly newsletter Vitamins China E-News.

Subscribe to our Newsletter

 


Next Press